Core Viewpoint - RH, a luxury home furnishings retailer, has revised its full-year revenue growth forecast downward and reported disappointing Q2 results, leading to an 8% decline in stock price during after-hours trading [2][4] Revenue Analysis - RH's revenue increased by 8% year-over-year to $3.3 billion, with Q2 revenue also rising 8% to $899 million; however, over the past three years, revenue has experienced an average decline of 5% [5][6] - The company's performance is closely tied to the housing market, and ongoing high mortgage rates and sluggish home sales could lead to a decline in demand for luxury furniture, potentially causing revenues to stagnate or drop back to $3.0 billion [6][8] Margin Pressure - In the last twelve months, RH generated $324 million in operating income, resulting in a 9.9% operating margin, with a net income of $84 million, reflecting a modest 2.6% net margin [7] - Tariffs, inflation, and rising freight costs are exerting pressure on margins, which could decline from around 10% to mid-single digits, potentially halving earnings [7][8] Valuation Concerns - RH currently trades at $228 per share, with a high valuation of 58x earnings based on FY 2024 EPS of $3.92; if revenues plateau and margins decrease, earnings could drop to about $2.00–$3.00 per share [8][9] - A potential valuation adjustment could see the stock price fall to the $100–$120 range, representing a 50% decrease from current levels [8][9] Future Outlook - The transition to lower valuations and earnings may take two to four years to manifest, with upcoming Q3 results being crucial for investor sentiment [9] - Despite challenges, RH has strengths such as an affluent customer base, brand advantages, and potential growth opportunities in international markets and new categories [10]

Group 1 - RH reported weaker-than-expected second-quarter results with earnings of $2.93 per share, below the analyst estimate of $3.20, and revenue of $899.15 million, missing the Street estimate of $904.64 million [1] - Despite challenges, RH experienced industry-leading growth with a revenue increase of 8.4% and demand growth of 13.7% in the second quarter [2] - RH lowered its fiscal 2025 revenue outlook from a range of $3.49 billion to $3.59 billion to a new range of $3.46 billion to $3.53 billion, compared to the previous estimate of $3.52 billion [2] Group 2 - Following the earnings announcement, analysts adjusted their price targets for RH, with Telsey Advisory Group downgrading from Outperform to Market Perform and lowering the price target from $255 to $220 [8] - Barclays maintained an Overweight rating but reduced the price target from $436 to $385 [8] - Guggenheim reiterated a Buy rating and maintained a price target of $300 [8]

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades: Argus upgraded Air Products (APD) to Buy from Hold. The near environment has been challenging with industrial demand weakness and high input costs, but conditions are beginning to change, the firm tells investors in a research note.Barclays upgraded Aptiv (APTV) to Overweight from Equal Weight with a price target ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Core Insights - RH's shares fell 7% in premarket trading following weaker-than-expected results and lowered guidance due to tariff uncertainties [1][6] Financial Performance - For the second quarter, RH reported adjusted earnings per share of $2.93 and revenue of $899.2 million, which is an 8% year-over-year increase. However, these figures missed analyst expectations of $3.22 EPS and $904.6 million in revenue [2][6] - The company cited the "polarizing impact of tariff uncertainty" and the worst housing market in nearly 50 years as factors negatively affecting performance [2][3] Guidance and Outlook - RH revised its full-year adjusted EBITDA margin forecast to 19% to 20%, down from the previous estimate of 20% to 21%. Revenue growth is now anticipated to be between 9% to 11%, compared to the earlier estimate of 10% to 13% [3] - The company is taking steps to mitigate tariff costs, including moving production out of China and increasing operations at its North Carolina plant [3][6] Market Context - Year-to-date, RH shares have lost 42% of their value, reflecting broader market challenges and specific company issues [4]

Market Overview - U.S. stock futures are showing mixed performance as investors reflect on record-setting highs and anticipate crucial economic data and the Federal Reserve's interest rate decision next week [1][2] - Major indices closed at record highs, with the Dow Jones Industrial Average (DJI) gaining over 600 points and closing above 46,000 for the first time [3] Index Performance - S&P 500 (SPX) futures are slightly down by 0.1% to 0.2%, while Dow Jones (DJI) futures are down approximately 0.2% to 0.3% [2] - Nasdaq (IXIC) futures have seen a modest increase of around 0.1% [2] - The S&P 500 closed at 6,587.47, up 0.85%, and the Nasdaq Composite closed at 22,043.07, up 0.72% [3] Upcoming Events - The Federal Reserve's interest rate decision is scheduled for September 17, with expectations of a 25 basis point cut, bringing the federal funds rate to a range of 4% to 4.25% [5] - The Fed's updated "dot plot" is anticipated to indicate at least two additional rate cuts by the end of the year [5] - Key economic data releases include the Consumer Sentiment report, August retail sales, industrial production, and housing starts [6] Company-Specific News - Adobe (ADBE) shares rose in premarket trading after reporting better-than-expected fiscal third-quarter earnings and raising its full-year outlook [7] - Microsoft (MSFT) shares increased following the EU's acceptance of changes to its Teams platform and a non-binding agreement with OpenAI [12] - Nvidia (NVDA) stock futures indicate steady performance after a 3.85% increase in the past 24 hours and a 61.96% year-over-year rise [12] - RH (RH) shares fell 7% after missing sales and profit targets and lowering its full-year guidance [12] - Warner Bros. Discovery (WBD) shares soared 29% amid reports of a potential takeover bid from Paramount Skydance Corp. [12] - Ibex Ltd. (IBEX) surged 24.75% after announcing better-than-expected fourth-quarter results and strong guidance for fiscal year 2026 sales [12]

Analyst Downgrades - Goldman Sachs analyst downgraded Novartis AG from Neutral to Sell, lowering the price target from $119 to $118, with shares closing at $127.70 [3] - Mizuho analyst downgraded Applied Materials, Inc. from Outperform to Neutral, reducing the price target from $200 to $175, with shares closing at $170.15 [3] - Barclays analyst downgraded Constellation Brands, Inc. from Overweight to Equal-Weight, slashing the price target from $202 to $150, with shares closing at $142.98 [3] - Telsey Advisory Group analyst downgraded RH from Outperform to Market Perform, cutting the price target from $255 to $220, with shares closing at $228.12 [3] - B of A Securities analyst downgraded Array Technologies, Inc. from Neutral to Underperform, lowering the price target from $8 to $7, with shares closing at $7.85 [3]

Market Overview - US equity futures are slightly lower, with small caps lagging as the stock rally appears to be losing momentum, while major indexes reached all-time highs [1] - The S&P 500 futures fell by 0.1%, while Nasdaq 100 futures remained positive due to strong tech performance, particularly from Microsoft [1] - European stocks showed subdued performance as investors await the Federal Reserve meeting next week, with the Stoxx Europe 600 Index little changed [7] Company Performance - Microsoft shares rose by 1% in premarket trading after avoiding a significant antitrust penalty from the EU, leading the Magnificent 7 stocks [3] - Adobe's stock increased by approximately 3% following a strong quarterly revenue outlook, indicating positive returns from AI investments [4] - Alaska Air gained 2% after receiving a buy rating upgrade from UBS, achieving a clean sweep of buy ratings among analysts [4] - Array Technologies saw a decline of 5% after being downgraded to underperform by BofA due to tariff impacts [4] - RH's shares fell by 8% after the company reduced its full-year sales outlook, citing new US tariffs affecting its seasonal catalog [4] - Super Micro Computer's stock rose by 5% after announcing the availability of its Nvidia Blackwell Ultra solutions [4] - Warner Bros. Discovery shares increased by 6%, continuing a significant rally after news of a potential bid from Paramount Skydance [4] Economic Indicators - Analysts expect small caps to outperform larger indices over the next twelve months, with a potential 20% advance in the Russell 2000 compared to an 11% increase in the S&P 500 [6] - The market anticipates between two to three quarter-point rate cuts by the Federal Reserve by year-end, with some traders betting on a half-point cut next week [3][5] Commodity and Currency Movements - Commodities showed mixed results, with oil and base metals prices rising, while precious metals experienced declines [1][12] - The dollar rebounded from previous losses, with the yen lagging behind G-10 currency peers [10] Geopolitical and Trade Developments - US Treasury Secretary Scott Bessent is set to meet with Chinese Vice Premier He Lifeng next week to discuss trade and economic issues [21] - The US is pressuring G7 countries to impose higher tariffs on India and China regarding Russian oil purchases, which may impact market sentiment [17][37]

Group 1 - U.S. stock futures showed mixed results, with Dow futures declining approximately 100 points [1] - RH reported second-quarter earnings of $2.93 per share, missing the analyst estimate of $3.20, and quarterly revenue of $899.15 million, which fell short of the Street estimate of $904.64 million [1] - RH shares dropped 11.5% to $201.98 in pre-market trading following the earnings report [2] Group 2 - Rent the Runway, Inc. saw a significant decline of 27.1% to $5.75 in pre-market trading after reporting disappointing second-quarter EPS results [4] - Frequency Electronics Inc experienced an 11% drop to $30.56 in pre-market trading due to downbeat financial results for its first quarter [4] - Zhengye Biotechnology Holding Ltd fell 9.3% to $8.35 in pre-market trading after a previous decline of 11% [4] - Inventiva S.A. dipped 8.5% to $5.28 in pre-market trading after a 4% gain the previous day [4] - Kindly MD, Inc. declined 7.7% to $3.64 in pre-market trading [4] - Tronox Holdings plc fell 5.7% to $4.71 in pre-market trading, with Mizuho analyst John Roberts downgrading the stock from Neutral to Underperform and setting a $4 price target [4] - ABIVAX Société Anonyme decreased by 4.7% to $81.94 in pre-market trading [4] - Certara, Inc. fell 4.3% to $10.45 in pre-market trading [4]

Group 1 - U.S. stock futures showed mixed results, with Dow futures declining approximately 100 points [1] - RH reported second-quarter earnings of $2.93 per share, missing the analyst estimate of $3.20, and quarterly revenue of $899.15 million, which fell short of the expected $904.64 million [1] - RH shares dropped 11.5% to $201.98 in pre-market trading following the earnings report [2] Group 2 - Rent the Runway, Inc. saw a significant decline of 27.1% to $5.75 in pre-market trading after reporting disappointing second-quarter EPS results [4] - Frequency Electronics Inc experienced an 11% drop to $30.56 in pre-market trading due to downbeat financial results for its first quarter [4] - Zhengye Biotechnology Holding Ltd fell 9.3% to $8.35 in pre-market trading after a decline of 11% on the previous day [4] - Inventiva S.A. dipped 8.5% to $5.28 in pre-market trading after a 4% gain on Thursday [4] - Kindly MD, Inc. declined 7.7% to $3.64 in pre-market trading [4] - Tronox Holdings plc fell 5.7% to $4.71 in pre-market trading, with Mizuho analyst John Roberts downgrading the stock from Neutral to Underperform and setting a $4 price target [4] - ABIVAX Société Anonyme decreased by 4.7% to $81.94 in pre-market trading [4] - Certara, Inc. fell 4.3% to $10.45 in pre-market trading [4]